Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intragastric pH Profile of Esomeprazole, Lansoprazole, and Pantoprazole in NSAID Users
NCT00625274Phase 4Completed
- Sponsor
- AstraZeneca
- Start
- Jun 2004
- Primary completion
- Nov 2004
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of esomeprazole in gastroesophageal reflux disease (GERD), upper abdominal pain, nausea ((none)), sponsored by AstraZeneca. Started Jun 2004; status: completed.
02
Drugs
esomeprazole
03
Conditions
gastroesophageal reflux disease (GERD)upper abdominal painnausea ((none))
Beyond the preview
Go deeper on NCT00625274.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00625274.